New imaging method may spot tumor growth earlier after freezing treatment
NCT ID NCT06224283
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a detailed MRI analysis called radiomics can predict if a desmoid tumor will grow back after cryoablation (freezing treatment) better than standard methods. Researchers will follow 21 patients treated at one hospital to compare radiomics with usual size-based criteria. The goal is to catch signs of progression earlier, which could guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cryoablation
- What this could lead to
- If successful, this could lead to a better way to predict tumor progression early, helping doctors decide on treatment sooner.
- What could go wrong
- This is a small, early study with only 21 participants, so results may not apply to everyone. The focus is on improving prediction, not on a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Giancarlo Facchini
RECRUITINGBologna, 40136, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for rare tumor patients: chemo delivered directly to desmoid growths
- New hope for rare tumor patients: AL102 drug trial launches
- Can a Stress-Management program help young cancer patients cope?
- New Tamoxifen-Like drug tested for stubborn hormone cancers
- New drug FOG-001 takes on Hard-to-Treat cancers